De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.
Saved in:
| Title: | De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma. |
|---|---|
| Authors: | Xu D; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. xuduo@jsph.org.cn., Gao Y; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Liu S; Department of Cardiothoracic Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Yin S; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Hu T; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Deng H; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Zhang T; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Hegedüs B; Department of Thoracic Surgery, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Tüschener Weg 40, 45239, Essen, Germany., Marti TM; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Dorn P; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Liang SQ; Department of Medicine, University of Minnesota Twin Cities, 516 Delaware Street SE, Minneapolis, MN, USA., Schmid RA; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Peng RW; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Renwang.Peng@insel.ch.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Renwang.Peng@insel.ch., Shu Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. shuyongqian@csco.org.cn. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2025 Sep; Vol. 17 (9), pp. 2258-2298. Date of Electronic Publication: 2025 Jul 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40707702 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xu+D%22">Xu D</searchLink>; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. xuduo@jsph.org.cn.<br /><searchLink fieldCode="AU" term="%22Gao+Y%22">Gao Y</searchLink>; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liu+S%22">Liu S</searchLink>; Department of Cardiothoracic Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Yin+S%22">Yin S</searchLink>; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Hu+T%22">Hu T</searchLink>; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Deng+H%22">Deng H</searchLink>; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zhang+T%22">Zhang T</searchLink>; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hegedüs+B%22">Hegedüs B</searchLink>; Department of Thoracic Surgery, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Tüschener Weg 40, 45239, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Marti+TM%22">Marti TM</searchLink>; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dorn+P%22">Dorn P</searchLink>; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liang+SQ%22">Liang SQ</searchLink>; Department of Medicine, University of Minnesota Twin Cities, 516 Delaware Street SE, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Schmid+RA%22">Schmid RA</searchLink>; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Peng+RW%22">Peng RW</searchLink>; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Renwang.Peng@insel.ch.; Department for BioMedical Research (DBMR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Renwang.Peng@insel.ch.<br /><searchLink fieldCode="AU" term="%22Shu+Y%22">Shu Y</searchLink>; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. shuyongqian@csco.org.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101487380%22">EMBO molecular medicine</searchLink> [EMBO Mol Med] 2025 Sep; Vol. 17 (9), pp. 2258-2298. <i>Date of Electronic Publication: </i>2025 Jul 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22EMBO+Press%22">EMBO Press </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101487380 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-4684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217574676%22">17574676 </searchLink><i>NLM ISO Abbreviation: </i>EMBO Mol Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40707702 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s44321-025-00278-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2258 Titles: – TitleFull: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xu D – PersonEntity: Name: NameFull: Gao Y – PersonEntity: Name: NameFull: Liu S – PersonEntity: Name: NameFull: Yin S – PersonEntity: Name: NameFull: Hu T – PersonEntity: Name: NameFull: Deng H – PersonEntity: Name: NameFull: Zhang T – PersonEntity: Name: NameFull: Hegedüs B – PersonEntity: Name: NameFull: Marti TM – PersonEntity: Name: NameFull: Dorn P – PersonEntity: Name: NameFull: Liang SQ – PersonEntity: Name: NameFull: Schmid RA – PersonEntity: Name: NameFull: Peng RW – PersonEntity: Name: NameFull: Shu Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1757-4684 Numbering: – Type: volume Value: 17 – Type: issue Value: 9 Titles: – TitleFull: EMBO molecular medicine Type: main |
| ResultId | 1 |